The Latest Breaking News from Pfizer

The mRNA vaccine story during the COVID-19 pandemic placed an extraordinary premium on altruism on the part of scientists

The 2023 Nobel Prize in physiology or medicine will go to Katalin Karikó and Drew Weissman for their discovery that modifying mRNA – a form of genetic material your body uses to produce proteins – could reduce unwanted inflammatory responses and allow it to be delivered into cells. While the…

Pfizer stock faces a steep patent cliff, but it's taken steps to offset the coming pressures. Will it be enough?

New shots for COVID and RSV are available, if people can actually get them, let alone want them

Some recent economic data points have revived recession fears, sending equities sharply lower this September. Here are 3 recession-proof stocks that conservative investors can consider now.

A major Pfizer pharmaceutical plant has restarted production, 10 weeks after it was heavily damaged by a tornado

Shares of Pfizer and Citigroup are languishing near their 52-week lows. However, both stocks offer dividend yields in excess of 5%, and investors might want to buy these two undervalued income plays at current levels.

The shot will help shield newborns from RSV in the early months of life, when they're especially vulnerable to severe illness.

U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns